ScoreWhy is Xiangxue Pharmaceutical Co., Ltd. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -15.03% and Operating profit at -219.62% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
With a fall in EPS of -12.39%, the company declared Very Negative results in Sep 25
- The company has declared negative results for the last 4 consecutive quarters
- NET PROFIT(HY) At CNY -273.76 MM has Grown at -50.44%
- INTEREST(HY) At CNY 146.1 MM has Grown at 15.81%
- ROCE(HY) Lowest at -83.57%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 16.83%, its profits have fallen by -105.4%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Xiangxue Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Xiangxue Pharmaceutical Co., Ltd.
16.83%
3.26
56.99%
China Shanghai Composite
15.17%
1.02
14.86%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-15.03%
EBIT Growth (5y)
-219.62%
EBIT to Interest (avg)
-0.99
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.24
Sales to Capital Employed (avg)
0.44
Tax Ratio
2.04%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.67%
ROE (avg)
0.51%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
8.80
EV to EBIT
-16.23
EV to EBITDA
-25.33
EV to Capital Employed
2.42
EV to Sales
7.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-14.88%
ROE (Latest)
-116.81%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
NET PROFIT(HY)
Higher at CNY -273.76 MM
RAW MATERIAL COST(Y)
Fallen by -102.09% (YoY
-32What is not working for the Company
NET PROFIT(HY)
At CNY -273.76 MM has Grown at -50.44%
INTEREST(HY)
At CNY 146.1 MM has Grown at 15.81%
ROCE(HY)
Lowest at -83.57%
DEBT-EQUITY RATIO
(HY)
Highest at 301.91 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.51 times
NET SALES(Q)
Lowest at CNY 320.56 MM
Here's what is working for Xiangxue Pharmaceutical Co., Ltd.
Net Profit
Higher at CNY -273.76 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CNY MM)
Raw Material Cost
Fallen by -102.09% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Xiangxue Pharmaceutical Co., Ltd.
Net Profit
At CNY -273.76 MM has Grown at -50.44%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Net Sales
At CNY 320.56 MM has Fallen at -18.54%
over average net sales of the previous four periods of CNY 393.54 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Interest
At CNY 146.1 MM has Grown at 15.81%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Debt-Equity Ratio
Highest at 301.91 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 1.51 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Net Sales
Lowest at CNY 320.56 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
